Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, the Financial Times reported on Tuesday, citing unnamed sources.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease , in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo
Moderna’s proposed price would apply to the United States and other high-income countries, according to the report. Pfizer, Moderna and Merck & Co have said they plan to sell their vaccines at a profit, while some drugmakers, including Johnson & Johnson have announced plans to price their vaccines on a not-for-profit basis.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pitch deck: Fintech ComplyAdvantage raises $50 million from SpaceX backer, VCs - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
Aerie Has A New Activewear Brand & Almost Everything Is Under $50American Eagle Outfitters announced its new brand, OFFLINE, a sub-brand of its intimates line Aerie, focusing on athletic wear.
続きを読む »
Final test of Moderna's coronavirus vaccine — in 30,000 volunteers — gets underwayThe world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers.
続きを読む »
Dr. Anthony Fauci isn't 'particularly concerned' about safety of Moderna coronavirus vaccine
続きを読む »
Moderna gets further $472 million U.S. award for coronavirus vaccine developmentModerna said on Sunday it has received an additional $472 million from the U.S. government's Biomedical Advanced Research and Development Authority to support the development of its novel coronavirus vaccine.
続きを読む »